Literature DB >> 20211164

Cell death mechanisms: cross-talk and role in disease.

Boris Zhivotovsky1, Sten Orrenius.   

Abstract

Multiple cell death mechanisms operate in both uni- and multicellular organisms. Hence, research during the past forty years has revealed that apoptosis is not the only cell death program involved in the regulation of tissue homeostasis and the removal of unwanted cells in biological organisms. While the molecular pathways of apoptosis and necrosis are now relatively well established, the precise mechanisms of other cell death modalities, and their cross-talk, require additional study. This is particularly important, since many human disorders can be attributed, directly or indirectly, to defective cell death mechanisms. In this review we shall discuss the characteristics and cross-talk between various modes of cell death and their role in cell death-related disorders, notably, neurodegenerative disease and cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20211164     DOI: 10.1016/j.yexcr.2010.02.037

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

Review 1.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

Review 2.  Screening for chemicals that affect hair cell death and survival in the zebrafish lateral line.

Authors:  Henry Ou; Julian A Simon; Edwin W Rubel; David W Raible
Journal:  Hear Res       Date:  2012-01-31       Impact factor: 3.208

Review 3.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

4.  Insights into the structural stability of Bax from molecular dynamics simulations at high temperatures.

Authors:  Jorge Luis Rosas-Trigueros; José Correa-Basurto; Claudia Guadalupe Benítez-Cardoza; Absalom Zamorano-Carrillo
Journal:  Protein Sci       Date:  2011-11-01       Impact factor: 6.725

5.  Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.

Authors:  Aviv Cohen; Jenny Lerner-Yardeni; David Meridor; Roni Kasher; Ilana Nathan; Abraham H Parola
Journal:  Mol Med       Date:  2015-06-04       Impact factor: 6.354

6.  Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.

Authors:  Chung Soo Lee; Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim; Min Won Lee
Journal:  Invest New Drugs       Date:  2010-12-01       Impact factor: 3.850

7.  Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins.

Authors:  Yun Jeong Kim; Seon Ae Lee; Soon Chul Myung; Wonyong Kim; Chung Soo Lee
Journal:  Mol Cell Biochem       Date:  2011-07-29       Impact factor: 3.396

Review 8.  Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function.

Authors:  Antero Salminen; Anu Kauppinen; Mikko Hiltunen; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2013-11-28       Impact factor: 9.261

9.  Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion.

Authors:  Yun Jeong Kim; Yong Kyoo Shin; Dong Suep Sohn; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-31       Impact factor: 3.000

10.  The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients.

Authors:  Agnieszka Pluta; Tadeusz Robak; Barbara Cebula; Agata Majchrzak; Piotr Pluta; Kamil Brzozowski; Konrad Stępka; Anna Szmigielska-Kapłon; Olga Grzybowska-Izydorczyk; Magdalena Czemerska; Piotr Smolewski; Agnieszka Wierzbowska
Journal:  Arch Med Sci       Date:  2019-11-19       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.